Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.33 |
| ▸ | TUBB | P07437 | 1/20 | 0.33 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.33 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.33 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.33 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.33 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.33 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.33 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.33 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.33 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.33 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20857779 | 0.93 | ALDH1A1 (0.36) | GSTP1GPR84CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL20857939 | 0.87 | RET (0.31) | — | |
| SCHEMBL23775682 | 0.84 | GSTP1 (0.32) | GSTP1HDAC4HDAC2HDAC8GPR84 | |
| SCHEMBL20857893 | 0.84 | GPR84 (0.36) | GSTP1HSD17B1HSD17B2HDAC4HDAC2 | |
| SCHEMBL19863142 | 0.84 | ESR1 (0.36) | GSTP1HSD17B1HSD17B2HDAC4HDAC2 | |
| SCHEMBL20857932 | 0.84 | HSD17B10 (0.39) | KDM4E | |
| SCHEMBL20858026 | 0.84 | HSD17B10 (0.41) | KDM4EALOX5 | |
| SCHEMBL19863136 | 0.84 | GSTP1 (0.34) | GSTP1HSD17B1HSD17B2HDAC4HDAC2 | |
| SCHEMBL22568582 | 0.83 | KDM4E (0.32) | KDM4E | |
| SCHEMBL25459727 | 0.82 | KDM4E (0.37) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-11569449-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-31 | — | — | US | disclosed |
| US-20210336149-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
| WO-2021065772-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE | 出光興産株式会社 | 2021-04-08 | — | — | WO | disclosed |
| EP-3723149-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND NOVEL COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2020-10-14 | — | — | EP | disclosed |
| US-10680181-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-09 | — | — | US | disclosed |
| US-10672989-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-02 | — | — | US | disclosed |
| US-10658594-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20190355914-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-11-21 | — | — | US | disclosed |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20190194215-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| US-10249832-B1 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2019-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128708-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | GSTP1 2441/4885HSD17B1 1201/4885HSD17B2 1512/4885 |
| US-10249832-B1 | Organic electroluminescence device and novel compound | OR10J3, KCNH3, OR51E2 | GSTP1 3982/4885HSD17B1 3277/4885HSD17B2 3542/4885 |
| US-10658594-B2 | Organic electroluminescence device and novel compound | OR10J3, OR51E2, TRPC6 | GSTP1 4344/4885HSD17B1 1597/4885HSD17B2 1771/4885 |
| US-10680181-B2 | Organic electroluminescence device and novel compound | PIEZO1, TMEM109, OXA1L | GSTP1 2441/4885HSD17B1 1201/4885HSD17B2 1512/4885 |
| US-20190194215-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | OR10J3, OR51E2, TRPC6 | GSTP1 4344/4885HSD17B1 1597/4885HSD17B2 1771/4885 |
| US-10672989-B2 | Organic electroluminescence device and novel compound | LEF1, OR10J3, LUC7L2 | GSTP1 2548/4885HSD17B1 2703/4885HSD17B2 2425/4885 |
| US-20190355914-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | PIEZO1, TMEM109, OXA1L | GSTP1 2441/4885HSD17B1 1201/4885HSD17B2 1512/4885 |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | KCNN4, OR10J3, KCNN2 | GSTP1 4310/4885HSD17B1 1354/4885HSD17B2 1518/4885 |
| US-11569449-B2 | Organic electroluminescence device and novel compound | PIEZO1, TMEM109, OXA1L | GSTP1 2441/4885HSD17B1 1201/4885HSD17B2 1512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.